Oct2/NN
transactivation/NN
from/IN
a/DT
remote/JJ
enhancer/NN
position/NN
requires/VBZ
a/DT
B-cell-restricted/JJ
activity/NN
./.

Previous/JJ
cotransfection/NN
experiments/NNS
had/VBD
demonstrated/VBN
that/IN
ectopic/JJ
expression/NN
of/IN
the/DT
lymphocyte-specific/JJ
transcription/NN
factor/NN
Oct2/NN
could/MD
efficiently/RB
activate/VB
a/DT
promoter/NN
containing/VBG
an/DT
octamer/NN
motif/NN
./.
=====
Oct2/NN
expression/NN
was/VBD
unable/JJ
to/TO
stimulate/VB
a/DT
multimerized/JJ
octamer/NN
enhancer/NN
element/NN
in/IN
HeLa/NN
cells/NNS
,/,
however/RB
./.
=====
We/PRP
have/VBP
tested/VBN
a/DT
variety/NN
of/IN
Oct2/NN
isoforms/VBZ
generated/VBN
by/IN
alternative/JJ
splicing/NN
for/IN
the/DT
capability/NN
to/TO
activate/VB
an/DT
octamer/NN
enhancer/NN
in/IN
nonlymphoid/JJ
cells/NNS
and/CC
a/DT
B-cell/NN
line/NN
./.
=====
Our/PRP$
analyses/NNS
show/VBP
that/IN
several/JJ
Oct2/NN
isoforms/NNS
can/MD
stimulate/VB
from/IN
a/DT
remote/JJ
position/NN
but/CC
that/IN
this/DT
stimulation/NN
is/VBZ
restricted/JJ
to/TO
B/NN
cells/NNS
./.
=====
This/DT
result/NN
indicates/VBZ
the/DT
involvement/NN
of/IN
either/CC
a/DT
B-cell-specific/JJ
cofactor/NN
or/CC
a/DT
specific/JJ
modification/NN
of/IN
a/DT
cofactor/NN
or/CC
the/DT
Oct2/NN
protein/NN
in/IN
Oct2-mediated/JJ
enhancer/NN
activation/NN
./.
=====
Mutational/JJ
analyses/NNS
indicate/VBP
that/IN
the/DT
carboxy-terminal/JJ
domain/NN
of/IN
Oct2/NN
is/VBZ
critical/JJ
for/IN
enhancer/NN
activation/NN
./.
=====
Moreover/RB
,/,
this/DT
domain/NN
conferred/VBD
enhancing/NN
activity/NN
when/WRB
fused/VBN
to/TO
the/DT
Oct1/NN
protein/NN
,/,
which/WDT
by/IN
itself/PRP
was/VBD
unable/JJ
to/TO
stimulate/VB
from/IN
a/DT
remote/JJ
position/NN
./.
=====
The/DT
glutamine-rich/JJ
activation/NN
domain/NN
present/JJ
in/IN
the/DT
amino-terminal/JJ
portion/NN
of/IN
Oct2/NN
and/CC
the/DT
POU/NN
domain/NN
contribute/VBP
only/RB
marginally/RB
to/TO
the/DT
transactivation/NN
function/NN
from/IN
a/DT
distal/JJ
position/NN
./.